BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 21890224)

  • 1. Image-guided radiotherapy using surgical clips as fiducial markers after prostatectomy: a report of total setup error, required PTV expansion, and dosimetric implications.
    Song S; Yenice KM; Kopec M; Liauw SL
    Radiother Oncol; 2012 May; 103(2):270-4. PubMed ID: 21890224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptive radiotherapy and the dosimetric impact of inter- and intrafractional motion on the planning target volume for prostate cancer patients.
    Böckelmann F; Putz F; Kallis K; Lettmaier S; Fietkau R; Bert C
    Strahlenther Onkol; 2020 Jul; 196(7):647-656. PubMed ID: 32157345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy.
    Stanic S; Mathai M; Cui J; Purdy JA; Valicenti RK
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1897-902. PubMed ID: 21536391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential failure risk of the cone-beam computed tomography-based planning target volume margin definition for prostate image-guided radiotherapy based on a prospective single-institutional hybrid analysis.
    Hirose K; Sato M; Hatayama Y; Kawaguchi H; Komai F; Sohma M; Obara H; Suzuki M; Tanaka M; Fujioka I; Ichise K; Takai Y; Aoki M
    Radiat Oncol; 2018 Jun; 13(1):106. PubMed ID: 29880006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of planning target volume margin for a small number of vertebral metastatic lesions using image-guided intensity-modulated radiation therapy by helical tomotherapy.
    Nishimura T; Yamazaki H; Iwama K; Kotani T; Oota Y; Aibe H; Nakamura S; Ikeno H; Yoshida K; Isohashi F; Okabe H
    Anticancer Res; 2013 Jun; 33(6):2453-6. PubMed ID: 23749895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determining optimal planning target volume and image guidance policy for post-prostatectomy intensity modulated radiotherapy.
    Bell LJ; Cox J; Eade T; Rinks M; Herschtal A; Kneebone A
    Radiat Oncol; 2015 Jul; 10():151. PubMed ID: 26209446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTV margin definition in hypofractionated IGRT of localized prostate cancer using cone beam CT and orthogonal image pairs with fiducial markers.
    Oehler C; Lang S; Dimmerling P; Bolesch C; Kloeck S; Tini A; Glanzmann C; Najafi Y; Studer G; Zwahlen DR
    Radiat Oncol; 2014 Nov; 9():229. PubMed ID: 25384898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative evaluation of the benefit of fiducial image-guidance for prostate cancer intensity modulated radiation therapy using daily dose volume histogram analysis.
    Kasaova L; Sirak I; Jansa J; Paluska P; Petera J
    Technol Cancer Res Treat; 2014 Feb; 13(1):47-55. PubMed ID: 23819493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An image-guided study of setup reproducibility of postmastectomy breast cancer patients treated with inverse-planned intensity modulated radiation therapy.
    Feng CH; Gerry E; Chmura SJ; Hasan Y; Al-Hallaq HA
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):58-64. PubMed ID: 25442344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Image-guided intensity-modulated radiotherapy of prostate cancer: Analysis of interfractional errors and acute toxicity.
    Rudat V; Nour A; Hammoud M; Alaradi A; Mohammed A
    Strahlenther Onkol; 2016 Feb; 192(2):109-17. PubMed ID: 26545764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superiority of a soft tissue-based setup using cone-beam computed tomography over a bony structure-based setup in intensity-modulated radiotherapy for prostate cancer.
    Sato H; Abe E; Utsunomiya S; Kaidu M; Yamana N; Tanaka K; Ohta A; Obinata M; Liu J; Kawaguchi G; Maruyama K; Ayukawa F; Aoyama H
    J Appl Clin Med Phys; 2015 Sep; 16(5):239–245. PubMed ID: 26699304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric impact and theoretical clinical benefits of fiducial markers for dose escalated prostate cancer radiation treatment.
    Gauthier I; Carrier JF; Béliveau-Nadeau D; Fortin B; Taussky D
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1128-33. PubMed ID: 19147306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inter- and intrafraction uncertainty in prostate bed image-guided radiotherapy.
    Huang K; Palma DA; Scott D; McGregor D; Gaede S; Yartsev S; Bauman G; Louie AV; Rodrigues G
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):402-7. PubMed ID: 22381905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the planning target volume in the treatment of head and neck cancer with intensity-modulated radiotherapy: what is the appropriate expansion margin in the setting of daily image guidance?
    Chen AM; Farwell DG; Luu Q; Donald PJ; Perks J; Purdy JA
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):943-9. PubMed ID: 20932680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimising the dosimetric quality and efficiency of post-prostatectomy radiotherapy: a planning study comparing the performance of volumetric-modulated arc therapy (VMAT) with an optimised seven-field intensity-modulated radiotherapy (IMRT) technique.
    Nguyen BT; Hornby C; Kron T; Cramb J; Rolfo A; Pham D; Haworth A; Tai KH; Foroudi F
    J Med Imaging Radiat Oncol; 2012 Apr; 56(2):211-9. PubMed ID: 22498196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric consequences of the application of off-line setup error correction protocols and a hull-volume definition strategy for intensity modulated radiotherapy of prostate cancer.
    Baum C; Birkner M; Alber M; Paulsen F; Nüsslin F
    Radiother Oncol; 2005 Jul; 76(1):35-42. PubMed ID: 16019092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of rectal and bladder variability on target coverage during post-prostatectomy intensity modulated radiotherapy.
    Bell LJ; Cox J; Eade T; Rinks M; Kneebone A
    Radiother Oncol; 2014 Feb; 110(2):245-50. PubMed ID: 24560757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of changing technique, dose, and PTV margin on therapeutic ratio during prostate radiotherapy.
    Huang SH; Catton C; Jezioranski J; Bayley A; Rose S; Rosewall T
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1057-64. PubMed ID: 18339487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the dosimetric impact of non-exclusion of the rectum from the boost PTV in IMRT treatment plans for prostate cancer patients.
    Kassim I; Dirkx ML; Heijmen BJ
    Radiother Oncol; 2009 Jul; 92(1):62-7. PubMed ID: 19278745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of anatomical interventions on the localization of post-prostatectomy cancer patients.
    Diot Q; Olsen C; Kavanagh B; Raben D; Miften M
    Med Phys; 2010 Feb; 37(2):629-37. PubMed ID: 20229872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.